+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Oncology Market - Global Forecast 2026-2032- Product Image
Veterinary Oncology Market - Global Forecast 2026-2032- Product Image
New

Veterinary Oncology Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305503
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The veterinary oncology market is experiencing a transformation as clinical advancements, collaborative partnerships, and technology adoption reshape approaches to animal cancer treatment. For senior decision-makers seeking clarity in this evolving sector, an informed, strategic perspective is critical when evaluating opportunities and managing risks.

Market Snapshot: Veterinary Oncology Market Size and Growth

The global veterinary oncology market expanded from USD 1.84 billion in 2025 to USD 2.09 billion in 2026, with a compound annual growth rate (CAGR) of 14.47%. The industry is on track to achieve USD 4.74 billion by 2032. This rapid trajectory is driven by heightened demand for animal cancer care and a marked shift toward advanced therapeutic solutions across veterinary clinics and specialty centers.

Scope & Segmentation

This analysis offers a comprehensive view of the veterinary oncology market, emphasizing segment-specific drivers, emerging innovations, and how regional variations affect clinical and operational priorities.

  • Animal Types: Covers canine, feline, equine, and exotic pets, including aquatic species, avian cases, and reptiles, each requiring different approaches in oncology practices and presenting varied challenges for clinicians and owners.
  • Treatment Modes: Includes chemotherapy, immunotherapy, radiotherapy, surgical interventions, and precision therapies featuring molecular profiling, relevant to a diverse range of cancer types.
  • Cancer Types: Addresses lymphoma, osteosarcoma, mammary carcinoma, mast cell tumors, and hemangiosarcoma, reflecting a need for tailored treatment protocols and care pathways for each diagnosis.
  • Administration Pathways: Highlights intravenous, oral, and topical administration, all of which can impact patient compliance, clinical workflow, and outcomes in different veterinary settings.
  • End Users: Applies to academic research centers, veterinary hospitals, and independent clinics, each with distinct roles in advancing animal cancer care and integrating new therapies.
  • Technologies: Encompasses diagnostic imaging, digital pathology, molecular diagnostics, and artificial intelligence-enabled platforms that support improved diagnostics, personalized care, and data-driven decision-making.
  • Regions: Focuses on the Americas, Europe, Middle East and Africa, and Asia-Pacific, where healthcare infrastructure maturity, regulatory policies, and adoption rates shape access to veterinary oncology services.

Key Takeaways for Strategic Decision-Makers

  • Adoption of advanced oncology approaches in veterinary medicine mirrors current trends in human healthcare, prompting investments in collaborative and multidisciplinary clinical models.
  • Integrating technologies such as digital pathology, molecular profiling, and telehealth tools allows for more accurate diagnostics and enables veterinarians to deliver precise, patient-specific interventions.
  • Partnerships among academic institutions, startups, and established manufacturers accelerate innovation cycles and promote faster clinical translation of research breakthroughs.
  • Development of local innovation hubs supports operational resilience, reducing dependence on international suppliers and strengthening regional supply chains.
  • Complexity in regulations and reimbursement frameworks demands ongoing agility by stakeholders, necessitating strategic planning to safeguard costeffectiveness and consistent access to care.

Tariff Impact on Supply Chains and Treatment Accessibility

New tariffs introduced in the United States in 2025 have increased costs for veterinary oncology inputs, such as active pharmaceutical ingredients and specialty devices. These conditions encourage clinics and suppliers to diversify sources, establish longer-term contracts, and prioritize local production. In response, the market is seeing the emergence of fresh regional alliances and refined supply-chain management tactics, all aimed at ensuring long-term stability and transparent delivery of cancer care for animals.

Veterinary Oncology Market Methodology & Data Sources

The research approach includes direct interviews with oncology specialists, veterinary hospital executives, and regulatory officials, combined with review of peer-reviewed literature, industry white papers, and proprietary market databases. Data reliability is reinforced through triangulation, expert validation, and scenario-based analysis for consistent, actionable findings.

Why This Report Matters for Senior Leaders

  • Offers actionable insights to support strategic investment, resource allocation, and targeted entry into high-growth market segments.
  • Delivers clarity on how regulatory shifts, cost structures, and emerging care models interact, simplifying decision-making processes for leadership teams.
  • Enables identification of partnering opportunities, technological adoption trends, and evolving roles of key stakeholders within the global animal oncology ecosystem.

Conclusion: Advancing Veterinary Oncology Through Strategic Foresight

By applying the insights in this report, senior executives can drive innovation, strengthen operational infrastructure, and build long-term advantages in veterinary oncology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Veterinary Oncology Market, by Animal Type
8.1. Canine
8.2. Equine
8.3. Exotic Pets
8.3.1. Aquatic Pets
8.3.2. Birds
8.3.3. Reptiles & Amphibians
8.4. Feline
9. Veterinary Oncology Market, by Treatment Mode
9.1. Chemotherapy
9.1.1. Alkylating Agents
9.1.2. Antimetabolites
9.1.3. Cytotoxic Agents
9.1.4. Vinca Alkaloids
9.2. Immunotherapy
9.2.1. Cancer Vaccines
9.2.2. Monoclonal Antibodies
9.3. Radiotherapy
9.3.1. Brachytherapy
9.3.2. External Beam Radiotherapy
9.4. Surgery
9.5. Targeted Therapy
10. Veterinary Oncology Market, by Cancer Type
10.1. Hemangiosarcoma
10.2. Lymphoma
10.3. Mammary Carcinoma
10.4. Mast Cell Tumors
10.5. Osteosarcoma
11. Veterinary Oncology Market, by Mode of Administration
11.1. Intravenous (IV)
11.2. Oral
11.3. Topical
12. Veterinary Oncology Market, by End User
12.1. Academic Institutions
12.2. Veterinary Hospitals & Clinics
13. Veterinary Oncology Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Veterinary Oncology Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Veterinary Oncology Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Veterinary Oncology Market
17. China Veterinary Oncology Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AB Science SA
18.6. Anivive Lifesciences
18.7. Ardent Animal Health, LLC
18.8. Boehringer Ingelheim International GmbH
18.9. Ceva Sante Animale S.A.
18.10. Covetrus, Inc.
18.11. Elanco Animal Health Incorporated
18.12. ELIAS Animal Health
18.13. Fidocure
18.14. IDEXX Laboratories, Inc.
18.15. Karyopharm Therapeutics Inc.
18.16. Leroy Biotech S.A.S.
18.17. Merck KGaA,
18.18. Morphogenesis, Inc.
18.19. Nippon Zenyaku Kogyo Co., Ltd.
18.20. PetCure Oncology LLC
18.21. PharmAust Limited
18.22. Rhizen Pharmaceuticals AG
18.23. Torigen Pharmaceuticals Inc.
18.24. Varian Medical Systems, Inc.
18.25. Vetco Pharmaceuticals Inc.
18.26. VetDC, Inc.
18.27. Virbac SA
18.28. VolitionRx Limited
18.29. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EQUINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EQUINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY AQUATIC PETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY AQUATIC PETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY AQUATIC PETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BIRDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BIRDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REPTILES & AMPHIBIANS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REPTILES & AMPHIBIANS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REPTILES & AMPHIBIANS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ALKYLATING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ALKYLATING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANTIMETABOLITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANTIMETABOLITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CYTOTOXIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CYTOTOXIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VINCA ALKALOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VINCA ALKALOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VINCA ALKALOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY HEMANGIOSARCOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY HEMANGIOSARCOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY HEMANGIOSARCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY CARCINOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY CARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY CARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY OSTEOSARCOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY OSTEOSARCOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY OSTEOSARCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY INTRAVENOUS (IV), BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY INTRAVENOUS (IV), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 165. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 166. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 186. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 187. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 188. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 189. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. GCC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GCC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 195. GCC VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 196. GCC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 197. GCC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 198. GCC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 199. GCC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 200. GCC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 201. GCC VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. GCC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 215. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 216. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 217. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 218. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 219. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 220. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. G7 VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. G7 VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 225. G7 VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 226. G7 VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 227. G7 VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 228. G7 VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 229. G7 VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 230. G7 VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. G7 VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NATO VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. NATO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 235. NATO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 236. NATO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 237. NATO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 238. NATO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 239. NATO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 240. NATO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 241. NATO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. NATO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. CHINA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 255. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 256. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
TABLE 257. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 258. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
TABLE 259. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 260. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 261. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 262. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Veterinary Oncology market report include:
  • AB Science SA
  • Anivive Lifesciences
  • Ardent Animal Health, LLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale S.A.
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health
  • Fidocure
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics Inc.
  • Leroy Biotech S.A.S.
  • Merck KGaA,
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • PetCure Oncology LLC
  • PharmAust Limited
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • Varian Medical Systems, Inc.
  • Vetco Pharmaceuticals Inc.
  • VetDC, Inc.
  • Virbac SA
  • VolitionRx Limited
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.09 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.74 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Veterinary Oncology Market Report 2025 - Product Image

Veterinary Oncology Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Veterinary Oncology - Global Strategic Business Report - Product Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report by Animal (Canine, Feline, Equine), Therapy (Radiotherapy, Surgery, Chemotherapy, Immunotherapy), Cancer Type with Growth Forecasts, 2025-2030 - Product Image

U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report by Animal (Canine, Feline, Equine), Therapy (Radiotherapy, Surgery, Chemotherapy, Immunotherapy), Cancer Type with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • United States
From

About the Veterinary Oncology Market

Veterinary Oncology is a specialized field of veterinary medicine that focuses on the diagnosis and treatment of cancer in animals. Veterinary oncologists are trained to diagnose and treat a variety of cancers, including lymphoma, mast cell tumors, and bone cancer. Treatment options may include chemotherapy, radiation therapy, and surgery. Veterinary oncologists also provide supportive care to help animals cope with the side effects of cancer treatment. Veterinary oncology is an important part of animal healthcare, as cancer is a leading cause of death in animals. Veterinary oncologists work closely with other veterinary specialists, such as surgeons and radiologists, to provide comprehensive care for animals with cancer. Some companies in the Veterinary Oncology market include VetDC, VetCancer, and VetCure Oncology. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.